Discover how BNDX, a USD-hedged European bond ETF, offers a 3.06% yield amid diverging monetary policies and economic trends ...
Analysts have been eager to weigh in on the Real Estate sector with new ratings on Broadstone Net Lease (BNL – Research Report), Brixmor ...
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
In a report released today, Tal Liani from Bank of America Securities maintained a Buy rating on Fortinet (FTNT – Research Report). The ...
Nutanix (NTNX) closed the most recent trading day at $70.85, moving -1.03% from the previous trading session. This move lagged the S&P 500's daily gain of 0.36%. On the other hand, the Dow registered ...
BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ranging from $70 to $118 ...
Hosted on MSN6d
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO?Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...
Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.
Gentex (NASDAQ:GNTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at B. Riley in a ...
Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war ...
Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback